Home / Press releases / Curio Wellness Launches Two Product Lines Focused on Gut Health and Active Lifestyles

Curio Wellness Launches Two Product Lines Focused on Gut Health and Active Lifestyles

Curio Wellness Launches Two Product Lines Focused on Gut Health and Active Lifestyles
Brand develops one of cannabis industry’s first lines of gastrointestinal aids, uses advanced plant science to deliver targeted solutions

(July 25, 2022) Timonium, Md.Curio Wellness, a cGMP-certified, vertically integrated medical cannabis company and market leading innovator of health and wellness products derived from cannabis, has announced the launch of two scientifically-developed product lines: GI by Curio and Move by Curio.

GI by Curio is a plant-powered collection designed to improve quality of life and offer accessible options for patients facing gut discomfort or symptoms such as bloating, cramps, and helping to improve the body’s gut health. Leveraging advanced science and Curio’s proprietary patent pending pulse technology, this is the one of the first gut-focused, cannabis-derived therapeutic lines by a cannabis brand nationwide.

The GI by Curio collection includes:

  • Soothe Vape and Tincture: For patients experiencing nausea or upset stomach, quick delivery is essential. The vape and tincture allow for a faster onset since the cannabinoids bypass the digestive system.
  • Stimulate Chew: The medicated chew was created to help patients who struggle with reduced or no appetite.
  • Comfort Tablet: Specifically formulated to address chronic GI issues, the patent pending GI: Comfort tablet doses CBG and low THC in multiple pulses released at different intervals.

Move by Curio is the company’s first line of topical products designed to offer targeted relief for those with active lifestyles. The collection includes three treatments — a topical balm, transdermal balm and transdermal gel — that are unscented and non-greasy for optimal and targeted application.

“Curio’s commitment to continuous product research and innovation stems from our mission to develop targeted therapeutics that are safe, effective and reliable for patients seeking alternative, plant-based relief,” said Sandra Hutson, Vice President, Innovation at Curio Wellness. “GI and Move are just two prime examples of how our clinical-based approach is helping to reimagine the way medicinal cannabis is delivered to patients who need it most.”

GI and Move join the company’s portfolio of innovative cannabis products that help address and alleviate symptoms for a wide array of medical conditions – from pain management to insomnia. GI by Curio is available exclusively at Curio’s flagship Far & Dotter wellness center in Timonium, Maryland until its statewide release on July 25. Move by Curio will be available in dispensaries across Maryland starting August 8.

Curio Wellness was the first cannabis producer in Maryland awarded cGMP certification, the same quality standard set by the FDA for the world’s leading pharmaceutical companies.

Read about our announcement here: http://www.prweb.com/releases/curio_wellness_launches_two_product_lines_focused_on_gut_health_and_active_lifestyles/prweb18798154.htm


About Curio Wellness
Founded in 2014 in Baltimore, Maryland, Curio Wellness is a cGMP certified, vertically integrated medical cannabis company and trusted healthcare partner. Recognized as the leading wellness brand in cannabis by BDS Analytics, Curio is committed to serving patients with targeted, effective, and reliable cannabis-based medicine. For more information visit https://curiowellness.com.